Susan J. Ward
No más puestos en curso
Perfil
Dr. Susan J.
Ward is on the Board of Directors at Provasculon, Inc.
Dr. Ward was previously employed as Senior Vice President & Corporate Officer by Millennium Pharmaceuticals, Inc., Vice President-Research by Wyeth Research, a Principal by Sterling Drug, Inc., and Independent Director by SelectX Pharmaceuticals, Inc.
She received her undergraduate degree from The University of Manchester, a graduate degree from The University of Manchester, and a doctorate degree from The University of Manchester.
Antiguos cargos conocidos de Susan J. Ward.
| Empresas | Cargo | Fin |
|---|---|---|
Provasculon, Inc.
 Provasculon, Inc. Pharmaceuticals: MajorHealth Technology Provasculon, Inc. developed new treatments for chronic wounds and cardiovascular diseases. The company was founded by Thomas Lee Richard and Vincent M. Segers in 2008 and was headquartered in Boston, MA. | Director/Miembro de la Junta | - |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
| Sterling Drug, Inc. | Corporate Officer/Principal | - |
Wyeth Research
 Wyeth Research Miscellaneous Commercial ServicesCommercial Services Part of Pfizer Inc., Wyeth Research discovers and develops platforms encompassing pharmaceuticals. The company is based in Cambridge, MA. | Director Técnico/Científico/I+D | - |
SelectX Pharmaceuticals, Inc.
 SelectX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SelectX Pharmaceuticals, Inc. engages in the discovery and development of aminoglycoside therapeutics for unmet medical needs. Its advanced program, development candidate SXP2523, is a next generation aminoglycoside antibiotic for drug resistant gram-negative hospital-acquired infections (HAIs); SXP2523 possesses broad spectrum coverage with potency against Pseudomonas, Klebsiella, Acinetobacter, E. coli, and Staphylococcus. The company was founded by Michael G. Chaparian and Charles R. Cantor in 2002 and is headquartered in Boston, MA. | Director/Miembro de la Junta | - |
Formación de Susan J. Ward.
| The University of Manchester | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
| Sterling Drug, Inc. | Consumer Non-Durables |
SelectX Pharmaceuticals, Inc.
SelectX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SelectX Pharmaceuticals, Inc. engages in the discovery and development of aminoglycoside therapeutics for unmet medical needs. Its advanced program, development candidate SXP2523, is a next generation aminoglycoside antibiotic for drug resistant gram-negative hospital-acquired infections (HAIs); SXP2523 possesses broad spectrum coverage with potency against Pseudomonas, Klebsiella, Acinetobacter, E. coli, and Staphylococcus. The company was founded by Michael G. Chaparian and Charles R. Cantor in 2002 and is headquartered in Boston, MA. | Health Technology |
Wyeth Research
Wyeth Research Miscellaneous Commercial ServicesCommercial Services Part of Pfizer Inc., Wyeth Research discovers and develops platforms encompassing pharmaceuticals. The company is based in Cambridge, MA. | Commercial Services |
Provasculon, Inc.
Provasculon, Inc. Pharmaceuticals: MajorHealth Technology Provasculon, Inc. developed new treatments for chronic wounds and cardiovascular diseases. The company was founded by Thomas Lee Richard and Vincent M. Segers in 2008 and was headquartered in Boston, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Susan J. Ward
